LOS ANGELES, Sept. 25, 2019 /PRNewswire/ -- The global skin antiseptic products market is anticipated to grow at a CAGR of around 6.7 % in terms of revenue during the forecast period 2019 – 2026.
The US Food and Drug Administration (FDA) has finalized a rule that bans the marketing of over-the-counter (OTC) healthcare antiseptic products containing triclosan or any of 23 other active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback